Burcu Yigit is Associate Director of Pharmacology focused on characterization and validation of Cartography’s modalities. Prior to joining Cartography, Burcu was a senior scientist at MiNK Therapeutics, developing iNKT cells as an allogeneic cell therapy platform. She completed her PhD in lab of Cox Terhorst at BIDMC/Harvard Medical School, focused on immune modulating effects of targeting SLAMF6 in chronic lymphocytic leukemia. In her spare time, she enjoys running, reading and spending time with her family, two cats and friends.
Recent Posts
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
- Cartography Biosciences Co-Founder and Chief Executive Officer Kevin Parker, Ph.D., Earns Spot on Endpoints News’ 20 Under 40 List
- Cartography Biosciences Appoints Industry Veteran as Chief Administrative and Legal Officer
Recent Comments
No comments to show.